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Summary 
 
Carefully orchestrated intercellular communication is an essential prerequisite for the development 
of multicellular organisms. In recent years, tunneling nanotubes (TNT) have emerged as a novel 
and widespread mechanism of cell-cell communication. However, the molecular basis of their 
formation is still poorly understood. In the present study we report that the transmembrane MHC 
class III protein LST1 induces the formation of functional nanotubes and is required for endogenous 
nanotube generation. Mechanistically, we found LST1 to induce nanotube formation by recruiting 
the small GTPase RalA to the plasma membrane and promoting its interaction with the exocyst 
complex. Furthermore, we determined LST1 to recruit the actin-crosslinking protein filamin to the 
plasma membrane and to interact with M-Sec, myosin and myoferlin. These results allow us to 
suggest a molecular model for nanotube generation. In this proposal LST1 functions as a membrane 
scaffold mediating the assembly of a multimolecular complex, which controls the formation of 
functional nanotubes. 
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Introduction 
 
Recently, tunneling nanotubes (TNTs) have been established as a novel and widespread mechanism 
of intercellular communication, for a current review see (Abounit and Zurzolo, 2012). Nanotubes 
were originally characterized as long (up to several cell diameters) and thin (50 - 200 nm diameter) 
membrane extensions connecting rat PC12 cells (Rustom et al., 2004) and are thought to be the 
mammalian equivalent to cytonemes found in the Drosophila wing imaginal disc (Ramirez-Weber 
and Kornberg, 1999). Transfer of organelles (Rustom et al., 2004), soluble markers (Watkins and 
Salter 2005) and electrical signals (Wang et al., 2010) between distant cells connected via 
nanotubes has been observed and points to a pivotal role of these structures in cell-cell 
communication. Nanotubes have been found to connect a wide range of immune cells like B cells 
(Gupta and DeFranco, 2003), T cells (Sowinski et al., 2008), macrophages (Onfelt et al., 2004), 
mast cells (Fifadara et al., 2010), NK cells (Chauveau et al., 2010) and dendritic cells (Watkins and 
Salter, 2005). Interestingly, nanotubes have also been reported to connect dendritic cells in vivo in 
the mouse cornea (Chinnery et al., 2008). However, nanotubes are not present exclusively in 
immune cells but are rather widespread structures found in a growing number of cells from different 
tissues (Rustom et al., 2004; Wang et al., 2010; Wittig et al., 2012). The recent discovery that 
nanotubes may connect bacteria from different species (Dubey and Ben-Yehuda, 2011) indicates 
that nanotubes are not an exclusively eukaryotic trait but a common means of intercellular 
communication in nature. The LST1 (Leukocyte Specific Transcript 1) gene is localized next to the 
TNF cluster of the HLA class III region (Holzinger et al., 1995) and is highly expressed in 
macrophages and dendritic cells (de Baey et al., 1997; Rollinger-Holzinger et al., 2000). While 
LST1 transcript levels are highest in immune cells, we found the LST1 protein to be expressed at 
comparable levels in human cells of hematopoetic and non-hematopoetic origin (Schiller et al., 
2009). LST1 expression is characterized by extensive alternative splicing. Depending on exon 
usage, the resulting isoforms are either short soluble molecules or transmembrane proteins. A 
definitive function for LST1 has not been determined yet, however, it has been proposed that LST1 
isoforms play an important role in regulating the immune response (Rollinger-Holzinger et al., 
2000) and enabling cell-cell communication (Raghunathan et al., 2001). Overexpression of 
transmembrane LST1 has been shown to induce the formation of thin membrane protrusions up to 
300 µm in length, which display a striking resemblance to nanotubes (Raghunathan et al., 2001). 
The effect of LST1 overexpression on cell morphology led us to question whether LST1 
transmembrane proteins are involved in the formation of tunneling nanotubes. 
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Results 
 
LST1 overexpression induces the formation of tunneling nanotubes 
 
The induction of long membrane protrusions caused by overexpression of LST1 transmembrane 
isoforms has been described previously (Raghunathan et al., 2001). We were able to confirm this 
finding by transiently overexpressing a transmembrane LST1-EGFP fusion protein in HeLa cells. 
Transfectants displayed numerous membrane protrusions (Fig. 1A), while cells expressing a 
transmembrane control fusion protein did not show an altered morphology (Fig. 1B). We found the 
LST1-induced membrane protrusions to be suspended above the substratum and to often connect 
distant cells (Fig. 1A, lower panel). This concordance with hallmark characteristics of tunneling 
nanotubes prompted us to term these structures TNT-like protrusions. Overexpression of LST1-
EGFP led to a significant increase in the percentage of cells displaying TNT-like protrusions (Fig. 
1C), similar results were obtained in other cell lines (supplementary material Fig. S1). The 
induction of TNT-like protrusions was not construct-specific, as the overexpression of a FLAG-
LST1 protein yielded a similar effect (supplementary material Fig. S2A-C). A more detailed 
analysis of the LST1-induced TNT-like structures revealed that they were significantly longer than 
the ones observed between transfected control cells (Fig. 1D; supplementary material Fig. S2D-F). 
This result is in line with our observation that in LST1 transfectants, TNT-like structures with a 
span of up to 200 µm could be detected; while in transfected control cells the extent of these 
structures never surpassed 60 µm (data not shown). Furthermore, LST1-EGFP was enriched in 
TNT-like structures and in vesicles found therein (Fig. 1A, arrow; supplementary material Fig. 
S3A, arrow). Since nanotubes were initially described to contain actin but not tubulin (Rustom et 
al., 2004), we used this criterion to characterize the LST1-induced TNT-like structures. In 
transfectants overexpressing LST1-EGFP, we found TNT-like structures to be actin-rich but to 
contain only traces of tubulin (Fig. 1E). To enable a more sensitive detection of tubulin, 
transfectants coexpressing EGFP-tubulin and LST1-mCherry fusion proteins were imaged by live-
cell confocal microscopy. Transfectants displayed TNT-like protrusions of different diameters and 
lengths; „thick“ and shorter protrusions clearly contained EGFP-tubulin while in „thin“ protrusions 
no EGFP-tubulin was detectable (Fig. 1F; supplementary material Fig. S3B, C). Our results suggest 
some heterogeneity in the LST1-induced TNT-like membrane protrusions, all structures contain 
actin but only structures of larger diameter enclose tubulin. These findings are in agreement with a 
report describing two classes of structurally distinct nanotubes (Onfelt et al., 2006). The functional 
significance of different types of cellular conduits is not known so far. A quantitative analysis of the 
two different types of TNT-like protrusions revealed LST1 to induce the formation of both classes 
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of structures (supplementary material Fig. S3G). In subsequent experiments we did not discriminate 
between thick and thin, long and short TNT-like protrusions. Further characterization revealed that 
the LST1-induced TNT-like protrusions were sensitive to fixation (supplementary material Fig. 
S3D) and therefore display the same sensitivity to mechanical stress as nanotubes (Rustom et al., 
2004). This finding also allowed us to postulate that most of the „long“ membrane protrusions we 
observed in cells overexpressing LST1-EGFP (supplementary material Fig. S1) may actually be 
TNT-like structures brought in contact with the substratum by the mechanical stress of fixation. 
Cocultivation of cells overexpressing either LST1-EGFP or LST1-mCherry fusion proteins 
demonstrated that the TNT-like protrusions induced by LST1 are not remnant structures of cell 
division (supplementary material Fig. S3E). A potential role of LST1 in nanotube formation was 
further substantiated by our finding that endogenous LST1 is enriched in nanotubes connecting 
HeLa cells (supplementary material Fig. S3F). In summary, the detailed characterization of 
membrane protrusions observed in cells overexpressing LST1 allows us to conclude that these 
structures exhibit all the typical characteristics of tunneling nanotubes. 
 
LST1 supports the formation of functional tunneling nanotubes 
 
Nanotubes enable intercellular vesicle and/or organelle transport. To determine whether LST1-
induced nanotubes were functional and could mediate cell-cell communication we discriminatively 
labelled LST1 and control transfected HeLa cells with the dyes CFSE (cytoplasm) and DiI 
(membrane/endocytic vesicles) followed by cocultivation (supplementary material Fig. S4). The 
percentage of CFSE-stained cells containing DiI-labelled vesicles was used as an indicator for the 
efficiency of nanotube-mediated transport. The vesicle transfer rate was significantly increased in 
cells overexpressing LST1 when compared to transfected control cells (Fig. 2A). This effect was 
not due to an increased rate of exosome secretion in cells overexpressing LST1 (supplementary 
material Fig. S5). Nanotube formation is dependent on actin polymerization (Gurke et al., 2008; 
Bukoreshtliev et al., 2009). Treatment of the cocultures with the inhibitor of actin polymerization 
latrunculin-A led to a decrease in vesicle transfer and completely abrogated the effect of LST1 
overexpression on the transfer rate (Fig. 2A). Thus the observed effect depends on de novo actin 
polymerization. These results indicate that both LST1 and control transfected HeLa cells exchange 
vesicles and/or organelles via nanotubes and that LST1 overexpression induced the formation of 
additional functional nanotubes, which significantly enhanced the transfer rate in transfected cells. 
To determine whether LST1 is required for nanotube formation we stably transfected HeLa cells 
with a vector expressing shRNA targeting LST1. The downregulation of LST1 protein expression 
was confirmed by western blot analysis (supplementary material Fig. S6). The effect of LST1 knock 
down on the formation of functional nanotubes was examined as above. Knock down of LST1 
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resulted in a significant decrease of the vesicle transfer rate when compared to control transfectants 
(Fig. 2B). The negative effect of LST1 depletion on nanotube formation was confirmed by directly 
staining LST1 shRNA transfectants. LST1 knock down resulted in a significant decrease in the 
percentage of cells displaying nanotubes (Fig. 2C). These results further support the notion that 
transmembrane LST1 is required for nanotube formation. To elucidate the molecular mechanism 
underlying LST1-induced nanotube formation we examined the role of small GTPases in this 
process. Small GTPases have been shown to be key regulators of cytoskeletal remodelling 
(Heasman et al., 2008). Moreover, the Ras-like small GTPase RalA has been shown to be required 
for nanotube formation (Hase et al., 2009). We coexpressed LST1-EGFP and mutant GTPases and 
evaluated their effects on nanotube formation. The expression of GTPases was monitored by 
western blot analysis (supplementary material Fig. S7). The mutants RalA-28N, Cdc42-17N and 
Rac1-17N exclusively bind GDP and therefore induce a dominant negative effect. Overexpression 
of RalA-28N completely blocked LST1-induced nanotube formation, while Cdc42-17N only 
caused a modest reduction and Rac1-17N had no effect (Fig. 2D). The mutants RalA-38R and 
RalA-48W do not interact with the exocyst components Sec5 and Exo84 respectively. 
Overexpression of both RalA-38R and RalA-48W also completely blocked LST1-induced nanotube 
formation (Fig. 2D). These results indicate that RalA and its interaction with components of the 
exocyst complex are required for LST1-induced nanotube formation. Our findings are in line with 
the results of Hase et al. who first reported a role for RalA and the exocyst complex in nanotube 
formation. 
 
LST1 interacts with RalA, M-Sec and the exocyst complex 
 
The finding that RalA and the exocyst complex are involved in LST1-induced nanotube formation 
prompted us to test whether these proteins interact directly. Coexpression of LST1-EGFP and Myc-
RalA in HEK-293T cells, followed by immunoprecipitation revealed that Myc-RalA clearly 
coprecipitated with the LST1-EGFP fusion protein, but not with EGFP alone (Fig. 3A). The 
interaction between LST1 and RalA was confirmed in further experiments. Endogenous RalA 
coprecipitated with LST1-EGFP (Fig. 3B) and endogenous LST1 coprecipitated with a mCherry-
RalA fusion protein (Fig. 3C). Having found several dominant negative RalA mutants to block 
LST1-induced nanotube formation, we tested whether these mutations impaired binding of RalA to 
LST1. However, we found all assayed mutant proteins to clearly coprecipitate with LST1-EGFP in 
comparable amounts (supplementary material Fig. S8A). This observation implies that LST1 
interacts with RalA independently of whether GDP or GTP is bound. Next we examined a possible 
interaction between LST1 and the exocyst complex. We found Sec5 to clearly coprecipitate with 
LST1-EGFP but not with EGFP alone (Fig. 3D). Additional experiments revealed that further 
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components of the exocyst complex also coprecipitated with LST1-EGFP, although to a lesser 
extent than Sec5 (supplementary material Fig. S8B, C). These results demonstrate that Sec5 is the 
main interacting protein for LST1 in the exocyst complex. RalA is a known interactor of Sec5 
(Moskalenko et al., 2002); it is thus plausible that RalA mediates binding of LST1 to Sec5. To test 
this hypothesis, we coexpressed LST1-EGFP and either Myc-RalA, Myc-RalA-38R or a control 
vector. Overexpression of Myc-RalA did not enhance binding of LST1 to Sec5 (supplementary 
material Fig. S8D, E). On the other hand, overexpression of Myc-RalA-38R, a dominant negative 
mutant unable to bind to Sec5, did not impair the interaction between LST1 and Sec5 
(supplementary material Fig. S8D, E). We therefore concluded that RalA does not mediate LST1-
Sec5 binding and that these molecules interact directly. This finding prompted the question whether 
LST1 plays a role in the interaction between RalA and Sec5. To investigate this possibility we 
coexpressed mCherry-RalA and either LST1-EGFP or EGFP. Overexpression of LST1-EGFP 
significantly enhanced coprecipitation of Sec5 with mCherry-RalA (Fig. 3E, F). Thus we conclude 
that LST1 promotes the RalA-Sec5 interaction. Exo84, a further component of the exocyst complex 
has also been described to be an interactor of RalA (Moskalenko et al., 2003). However, 
overexpression of LST1-EGFP did not promote the RalA-Exo84 interaction (supplementary 
material Fig. S8F, G), indicating that LST1 selectively promotes the interaction between RalA and 
Sec5. In a previous study M-Sec was found to induce nanotube formation by interacting with RalA 
and signalling through the Ral-exocyst pathway (Hase et al., 2009). Further coprecipitation 
experiments revealed that LST1 clearly interacts with M-Sec (Fig. 3G). Taken together our results 
indicate that LST1 is a central component of the M-Sec-RalA-exocyst pathway, which controls 
nanotube formation. 
 
LST1 recruits RalA to the plasma membrane 
 
To gain further insights into the mechanism underlying LST1-induced nanotube formation, we 
characterized the interaction between RalA and LST1. In HeLa cells coexpressing LST1-EGFP and 
mCherry-RalA, both proteins colocalized in nanotubes (Fig. 4A; supplementary material Fig. S9A) 
and were enriched at the plasma membrane in sites of nanotube formation (Fig. 4B). Furthermore, 
we found overexpression of LST1-EGFP to significantly increase plasma membrane localization of 
mCherry-RalA (Fig. 4C–E). In control transfectants, mCherry-RalA localized to the plasma 
membrane and was also distributed throughout the cytoplasm and in internal membranes (Fig. 4C; 
supplementary material Fig. S9B), a subcellular allocation resembling that of endogenous RalA 
(Lim et al., 2010). In transfectants overexpressing LST1-EGFP, mCherry-RalA fusion protein at the 
plasma membrane predominated and was scarcely found in the cytoplasm and internal membranes 
(Fig. 4D; supplementary material Fig. S9C). This result indicates that RalA is recruited to the 
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plasma membrane by LST1 from a cytoplasmic RalA protein pool. Overexpression of mCherry-
RalA in LST1 shRNA transfectants (see supplementary material Fig. S6) resulted in a modest but 
significant decrease in membrane localization (Fig. 4F). This result led us to conclude, that while 
LST1 promotes membrane localization of RalA it is probably not the only factor involved in this 
process. We confirmed our findings by performing fluorescence recovery after photobleaching 
(FRAP) experiments. The recovery of mCherry-RalA fluorescence at the plasma membrane was 
significantly accelerated by the presence of LST1-EGFP (Fig. 4G, H). Taken together, our results 
demonstrate that LST1 actively recruits RalA to the plasma membrane. Next, we examined the 
interaction between LST1 and Sec5 more closely. In cells overexpressing LST1-EGFP, endogenous 
Sec5 colocalized with the fusion protein at the cell membrane and in nanotubes (supplementary 
material Fig. S10A, B). In contrast to RalA, overexpression of LST1 did not lead to an increased 
membrane localization of Sec5 (supplementary material Fig. S10C, D). Therefore, we suggest that 
LST1 interacts with Sec5 and the exocyst complex directly at the plasma membrane but is not 
involved in membrane recruitment of exocyst components.  
 
LST1 recruits filamin to the plasma membrane 
 
Having shown that LST1 induces the formation of functional nanotubes by recruiting RalA to the 
plasma membrane and promoting its interaction with the exocyst complex, we searched for further 
LST1-interacting proteins, which may contribute to nanotube formation. Analysis of LST1-EGFP 
precipitates from a stable HeLa transfectant revealed a noticeable coprecipitated band above 175 
kDa, which was absent in the precipitate from a control transfectant (Fig. 5A). Mass spectrometry 
analysis of this band identified filamin, myoferlin and the myosin II heavy chains MYH9/MYH10 
(supplementary material Table S1). These proteins were also identified in a mass spectrometry 
analysis of LST1-EGFP precipitate from transiently transfected HEK-293T cells (supplementary 
material Table S2). The identified proteins were confirmed to interact with LST1 by western blot 
analysis (supplementary material Fig. S11). Filamin is an effector of RalA, and interacts with GTP-
bound RalA (Ohta et al., 1999). Therefore we examined the role of filamin in LST1-induced 
nanotube formation. To test whether RalA mediates binding between LST1 and filamin, LST1-
EGFP was coexpressed with either the control vector, Myc-RalA or Myc-RalA-28N, a 
constitutively GDP-bound dominant negative mutant unable to interact with filamin. Coexpression 
of recombinant Myc-RalA led to a significant increase in the amount of filamin coprecipitated with 
LST1-EGFP, while coexpression of the mutant Myc-RalA-28N resulted in a significant decrease of 
bound filamin (Fig. 5B, C). These results indicate that RalA mediates the interaction between LST1 
and filamin. Staining of endogenous filamin in cells overexpressing LST1-EGFP revealed that both 
proteins colocalized at the cell membrane and in nanotubes (Fig. 5D). Furthermore, overexpression 
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of LST1-EGFP led to a significant increase in filamin membrane localization (Fig. 5D–F). 
However, coexpression of Myc-filamin with LST1-EGFP did not enhance the LST1-induced 
formation of nanotubes (supplementary material Fig. S12), indicating that filamin is not a limiting 
factor in this process. Taken together our results suggest that LST1 recruits filamin to the plasma 
membrane in a RalA-dependent manner. 
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Discussion 
 
Recent research has established tunneling nanotubes as a novel means of intercellular 
communication between distant cells and these structures have also been shown to play a key role 
in a number of pathological processes. Several viruses have been revealed to specifically hijack 
nanotubes for intercellular transfer, invisible to the immune system, to promote their rapid 
spreading (Sherer et al., 2007; Sowinski et al., 2008; Eugenin et al., 2009; Mukerji et al., 2012). 
Furthermore, nanotubes allow the intercellular transfer of prion protein in vitro and may be 
involved in the spreading of infectious prions in vivo (Gousset et al., 2009). The relevance of 
nanotube-mediated cell-cell communication in these pathological processes emphasizes the 
importance to understand the mechanisms by which cells regulate nanotube formation. In the 
present study we show that the transmembrane MHC class III protein LST1 induces the formation 
of functional tunneling nanotubes (Fig. 1). Furthermore, LST1 knock down reduces endogenous 
nanotube formation and impairs intercellular vesicle transfer (Fig. 2). Therefore, we postulate a 
molecular mechanism for the involvement of LST1 in nanotube formation. However, since LST1 
knock down did not completely abrogate TNT formation and vesicle transfer, either residual LST1 
protein is sufficient to partially enable the formation of nanotubes, and/or alternative LST1-
independent mechanisms exist. Tunneling nanotubes have been detected in immune cells, but also 
in cells from a wide range of tissues. LST1 mRNA expression is predominant in immune cells (de 
Baey et al., 1997; Rollinger-Holzinger et al., 2000). However, in a previous study we found the full-
length, transmembrane LST1 protein to be present in human cells of haematopoietic and non-
haematopoietic origin at comparable levels (Schiller et al., 2009). The widespread expression 
implies that its involvement in nanotube formation may not be restricted to immune cells. 
Furthermore, transmembrane LST1 is highly conserved in mammals (data not shown), pointing to 
an evolutionarily conserved function in nanotube genesis. Recently, Hase et al. reported a role for 
RalA and the exocyst complex in nanotube formation. In their study, M-Sec was described to 
promote nanotube formation by binding to RalA, which in turn interacted with the exocyst 
complex. However, it remained unclear, how the cytoplasmic protein M-Sec would be able to 
orchestrate the processes required to induce nanotubes. Coprecipitation and mass spectrometry 
analysis revealed interactions between LST1, RalA, M-Sec, filamin and several components of the 
exocyst complex (Fig. 3, 5; supplementary material Fig. S8, 11). The small GTPase RalA is a 
central regulator of cytoskeletal remodelling and exerts this function by signalling through three 
pathways: RalA targets filamin, an actin-crosslinking protein (Ohta et al., 1999), RalA mediates the 
assembly of the exocyst complex, which in turn regulates actin polymerization by activating the 
Arp2/3 complex (Jin et al., 2005; Zuo et al., 2006) and finally, RalA induces cytoskeletal 
remodelling by binding RalBP1, which activates Cdc42 (Ikeda et al., 1998). The recruitment of 
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RalA to the plasma membrane by LST1 and the RalA-dependent interaction between LST1 and 
filamin indicates that LST1 may direct actin-crosslinking to specific sites of the plasma membrane 
(Fig. 4). Our finding, that overexpression of filamin does not further enhance LST1-induced 
formation of nanotubes indicates that endogenous filamin protein levels are not a limiting factor in 
this process. The enhancement of the RalA-Sec5 interaction by LST1 (Fig. 3) raises the possibility 
that LST1 induces actin polymerization by promoting the RalA-mediated assembly of the exocyst 
complex. However, the role of the exocyst complex in the formation of nanotubes may not be 
restricted to the regulation of actin polymerization but could also involve membrane 
complementation by tethering vesicles to discrete regions of the plasma membrane. Hase et al. 
reported that the RalA-RalBP1-Cdc42 pathway may play a role in the elongation of nanotubes but 
is not central to their formation. Since a dominant negative mutant of Cdc42 only slightly inhibited 
LST1-induced nanotube formation (Fig. 2), we conclude that the LST1-RalA-filamin and LST1-
RalA-exocyst pathways constitute the central mechanisms of this process, while Cdc42 probably 
only plays a minor role. Further coprecipitation and mass spectrometry analyses revealed that LST1 
interacts with myoferlin and the myosin II heavy chains MYH9/MYH10 (Fig. 5). Myosin Ib and 
myosin IIa have been shown to promote the formation and scission of tubules at the trans-Golgi 
network by locally deforming the membrane and increasing membrane tension, respectively 
(Almeida et al., 2011; Miserey-Lenkei et al., 2010). The formation of long membrane protrusions 
like nanotubes would also require directed plasma membrane deformation, a process that could be 
mediated by myosin. Myoferlin is a member of the ferlin family and has been shown to enable 
membrane fusion between myoblasts (Doherty et al., 2005). Nanotubes establish cytoplasmic 
continuity between distant cells. This process requires punctual membrane fusion, which could be 
facilitated by myoferlin. However, it also appears feasible that the transmembrane LST1 protein 
itself is involved in membrane fusion. Nanotube-inducing LST1 isoforms are small asymmetric 
transmembrane polypeptides lacking a cleavable signal sequence that use an internal reverse signal-
anchor sequence for membrane insertion. They feature a glycine/leucine-rich transmembrane region 
followed by basic amino acid residues, structural motifs also found in fusion-associated small 
transmembrane (FAST) proteins encoded by fusogenic reoviruses (Clancy and Duncan, 2009). In 
summary, the results of this study allow us to propose a molecular model for the formation of 
LST1-induced tunneling nanotubes (Fig. 6). In this model, LST1 acts as a membrane scaffold for 
the assembly of a multiprotein complex that orchestrates the formation of nanotubes. Two pathways 
for membrane and cytoskeletal reorganization converge on LST1 at the plasma membrane, thereby 
spatially linking key processes, which are essential for the formation of LST1-induced nanotubes. 
First, LST1 recruits the small GTPase RalA and its effector filamin to the plasma membrane, 
thereby inducing localized actin-crosslinking. Second, LST1 promotes the interaction between 
RalA and the exocyst complex at the plasma membrane, thereby enabling exocyst-mediated actin 
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polymerization and membrane complementation. Additionally, the known inducer of nanotube 
formation M-Sec interacts with LST1 and RalA. The identification of myosin and myoferlin as 
LST1-interacting proteins raises the possibility that these proteins may contribute to the formation 
of open-ended nanotubes by locally deforming the plasma membrane and enabling membrane 
fusion. The mechanisms that trigger TNT protuberance remain unknown. Based on our model for 
LST1-induced TNT formation it seems plausible that enrichment of LST1 at specific sites of the 
plasma membrane may be the initial step. This event may be regulated by modification of LST1, 
since tyrosine phosphorylation and palmitoylation have been described (Draber et al., 2012). 
Plasma membrane accumulation of LST1 could also depend on cofactors not identified in this 
study. 
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Materials and methods 
 
Generation of expression constructs 
The EGFP-tubulin fusion vector was obtained from Clontech. The Myc-RalA-28N, Myc-RalA-
38R, Myc-RalA-48W, Myc-Cdc42-17N and Myc-Rac1-17N expression constructs have been 
described previously (Hase et al., 2009). The Myc-filamin-A expression construct was a gift from 
John Blenis (Woo et al., 2004 ; Addgene plasmid #8982). A construct for the expression of wild-
type Myc-RalA was generated using the Myc-RalA-28N expression construct and the Phusion site-
directed mutagenesis kit from Finnzymes, following the manufacturer’s instructions. Tagged 
expression constructs were created by fusing the sequence encoding the FLAG epitope with the 
appropriate cDNA using a semi-nested PCR approach. LST1 transcripts were amplified as described 
(Schiller et al., 2009). The FLAG-LST1.2345 insertion (encoding the full-length transmembrane 
isoform, named by exon usage) was cloned into the pcDNA 3.1 (-) expression vector (Invitrogen). 
The FLAG-LST1.2345 insertion was also cloned in frame into the pEGFP-N1 vector (Clontech). 
Additionally, the FLAG-LST1.2345 ORF was fused to cDNA encoding the red fluorescent protein 
mCherry (Shaner et al., 2004) and inserted into the pcDNA 3.1 (+) vector (Invitrogen), thus 
creating the LST1-mCherry fusion construct. A mCherry-RalA fusion construct was generated in 
the same manner by amplification of the wild-type RalA ORF. For the KIR2DS2-EGFP 
transmembrane control fusion construct, cDNA was amplified using primers specific for KIR2DS2 
and cloned into the pEGFP-N1 vector. For the FLAG-DAP12 transmembrane control construct, 
cDNA was amplified using primers specific for DAP12 and cloned into the pcDNA 3.1 (+) vector. 
The shRNA vectors for LST1 knock down were purchased from SABiosciences and contained the 
following insertions: LST1: 5´-CAAGCTCTGGATGAGGAACTT-3´ and Control: 5´-
GGAATCTCATTCGATGCATAC-3´.  
 
Antibodies and reagents 
Monoclonal antibodies against the FLAG (M2) and Myc (9E10) epitopes were obtained from 
Sigma-Aldrich and Roche, respectively. The monoclonal antibody against filamin (FLMN01) was 
from Dianova. The monoclonal antibody against RFP (5F8) used to detect mCherry has been 
described previously (Rottach et al., 2008). The monoclonal antibody against tubulin (WA-3) was a 
kind gift from M. Schliwa (Ludwig-Maximilians-Universität München, Germany). The generation 
of a monoclonal antibody against LST1 for use in western blot procedures (7E2) was described in a 
previous report (Schiller et al., 2009), an additional antibody for use in immunocytochemistry (2B1) 
was generated for the present study. Polyclonal antibodies against Exo70 (H-300), Exo84 (C-16), 
Sec6 (H-230), MYH9 (H-40), MYH10 (H-46) and myoferlin (H-111) were obtained from Santa 
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Cruz Biotechnology. Polyclonal antibodies against GFP, RalA and Sec5 were from Invitrogen, 
Millipore and Proteintech, respectively. TRITC-labelled phalloidin was from Sigma-Aldrich. For 
immunocytochemistry the following secondary antibodies were used: Alexa488-conjugated chicken 
anti-rat (Invitrogen), Cy5-conjugated goat anti-mouse and DyLight649-conjugated goat anti-rabbit 
(both from Jackson). For western blot analysis IRDye800CW-conjugated goat anti-mouse, anti-rat 
and anti-rabbit antibodies were used (Li-Cor).  
 
Cell culture, transfection and immunocytochemistry procedures 
HeLa (ATCC CCL-2.1), U2-OS (ATTC HTB-96) and HEK-293T (ATCC CRL-11268) cells were 
cultivated as recommended by ATCC. HeLa and U2-OS cells were transfected with Lipofectamine 
2000 (Invitrogen), following the manufacturer’s instructions and using a 1:1 DNA/reagent ratio. 
HEK-293T cells were transfected using PEI (Sigma-Aldrich) with the DNA/reagent ratio 1:4. 
Transfectants were analyzed 24 hours after transfection. HeLa stable transfectants were established 
by cultivation in growth medium containing 2 mg/ml G418 (PAA). Resulting clones were screened 
by FACS and western analysis. For immunocytochemistry cells were seeded on polylysin-coated 
cover slips, washed with PBS containing 0.02% Tween-20, fixated in 2% PFA + 0.1% GTA for 5 
min and permeabilized with PBS + 0.1% Triton X-100. Blocking was performed with PBS + 3% 
BSA. To prevent disruption of nanotubes all steps were performed avoiding direct light and wash 
steps were conducted without removing the entire liquid. 
 
Cocultivation and vesicle transfer assay 
HeLa cells were transfected as described above, transfection efficiency was monitored via FACS 
analysis and staining was performed as previously described (Schiller et al., 2009). Cocultivation 
experiments were only performed if transfection efficiency was at least 65% (usual range 68 – 
79%). Transfectants were stained either with CFSE or DiI (both from Invitrogen) according to the 
manufacturer’s instructions and cocultivated on polylysin coated cover slips for 6 hours prior to 
fixation. Treatment with latrunculin-A (Sigma-Aldrich) was performed at a concentration of 500 
nM for 5 hours. The cells were allowed to adhere for 1 hour before treatment with latrunculin-A, 
because direct treatment prevents adhesion. Thus, a certain background is observed due to vesicle 
transfer in this first hour of coculture, as described previously (Rustom et al., 2004). For each cover 
slip at least 100 random CFSE-stained cells were imaged by fluorescence microscopy. Images were 
scored for CFSE-stained cells containing DiI-stained vesicles and/or organelles by two independent 
observers (C.S. and I.R.). Organelle transfer rates were obtained by averaging the scores determined 
by the two observers. 
 
Immunoprecipitation, isolation of exosomes and western blot analysis 
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The immunoprecipitation of GFP or mCherry was performed using the GFP-Trap A or RFP-Trap A 
reagents from Chromotek. Exosomes were isolated by differential centrifugation (100000 g pellet) 
following an established protocol (Théry et al., 2006). Western blot analysis was performed as 
described before (Schiller et al., 2009); blot imaging and signal quantification were conducted using 
the Odyssey infrared imaging system (Li-Cor). For quantitative analysis, western blots were imaged 
at least three times using different excitation intensities. 
 
Microscopy 
For microscopy of fixated cells, cover slips were embedded in Vectashield (Vector Laboratories), 
for live-cell microscopy cells were seeded out in 35 mm µ-dishes (Ibidi) and Opti-MEM medium 
(Gibco). Fluorescence microscopy was performed on a TE 2000 S eclipse microscope (Nikon) 
using a 60x/1.25 NA plan oil immersion objective and a C-8484 camera (Hamamatsu Photonics). 
Images were acquired with the Wasabi software (version 2.0, Hamamatsu Photonics). Confocal 
microscopy was performed on a TCS-SP5 confocal laser scanning microscope (Leica) equipped 
with a 63x/1.4 NA plan-apochromat oil immersion objective. Fluorophores were excited with 488, 
561 and 633 nm laser lines. Images were acquired with the LAS AF software (version 2.0, Leica). 
For live-cell confocal microscopy the TCS-SP5 microscope was equipped with a heated chamber 
set to 37°C. For FRAP analysis of EGFP and mCherry-fused proteins, confocal image series were 
acquired with a frame size of 256 × 256 pixels and a pixel size of 100 nm. Plasma membrane 
sections measuring 7 x 1,5 µm were photobleached for 300 ms with the 458, 476, 488, 496, 514, 
561 and 596 nm laser lines set to maximum power at 100% transmission. Typically 20 pre-bleach 
(150 ms time interval) and 120 post-bleach (500 ms time interval) frames were recorded for each 
series. Quantitative evaluation was performed using the ImageJ software (version 1.44, NIH). The 
mean fluorescence intensities from all frames were background subtracted and normalized to the 
mean of the last 10 pre-bleach values. For each series the time for recovery of 50% of pre-bleach 
fluorescence intensity was calculated. 
 
Mass spectrometry procedures 
The gel pieces were reduced with 5 mM DTT for 15 min at 60°C and acetylated using freshly 
prepared 25 mM iodacetamide (IAA) solution for 15 min at room temperature in the dark. Then 
0.01 µg/µl trypsin solution (Sigma) in 50 mM ABC (ammonium bicarbonate) was added and after 
incubation for 10 min, 25 mM ABC was added to cover the gel pieces completely during digest at 
37°C over night. For elution, 100 µl of 60% ACN (acetonitril) / 0.1% TFA (trifluoroacetic acid) 
were added to the gel cubes and incubated for 15 minutes with shaking. The supernatant was 
transferred to a new tube and 100 µl of 99.9% ACN/0.1% TFA were added to the gel pieces. After 
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additional 30 min of incubation, the supernatants were pooled. The supernatants containing the 
eluted peptides were dried in a speedvac (UniEquip) and stored at -20°C. Dried prefractionation 
samples were thawed and dissolved in 60 µl of 2% ACN/0.5% TFA for 30 min at RT under 
agitation. Before loading, the samples were centrifuged for 5 min at 4°C. LC-MS/MS analysis was 
performed as described previously (Hauck et al., 2010), with a 120 min LC-gradient from 5 to 31% 
of buffer B (80% acetonitrile, 0.1% formic acid in HPLC-grade water) at 300 nl/min flow rate 
followed by a short 5-min gradient from 31 to 95% buffer B. From the MS prescan, the 10 most 
abundant peptide ions were selected for fragmentation with at least 200 counts and at least doubly 
charged. During fragment analysis a high-resolution (60,000 full-width half maximum) MS 
spectrum was acquired in the Orbitrap with a mass range from 200 to 1500 Da. The lock mass 
option was activated and every ion selected for fragmentation was excluded for 30 s by dynamic 
exclusion. The acquired spectra were loaded to the Progenesis software (version 2.5, Nonlinear) for 
label free quantification and analyzed as described previously (Hauck et al., 2010).  
 
Statistical analysis 
Differences between groups were tested for significance by applying the Mann-Whitney-U-test, 
using the BrightStat software (Stricker, 2008). Differences were considered significant at p < 0.05. 
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Figure Legends 
 
Figure 1. LST1 induces the formation of tunneling nanotubes. (A, B, E and F) Maximum 
intensity projections of confocal z-slides, images at the substratum plane were not included. Scale 
bar: 20 µm. (A and B) HeLa cells were transfected with constructs encoding either transmembrane 
LST1-EGFP (A) or a transmembrane KIR2DS2-EGFP control fusion protein (B). Overexpression 
of LST1-EGFP induced the formation of TNT-like protrusions (A) while KIR2DS2-EGFP readily 
localized to the plasma membrane but did not cause morphological changes in transfected cells (B). 
TNT-like structures lacked contact with the substratum and were often found to connect LST1-
EGFP transfectants (A, lower panel, yz-projection including the substratum plane). Note that the 
TNT-like structure contains an LST1-EGFP-enriched vesicle (A, arrow). (C and D) HeLa cells 
overexpressing LST1-EGFP or the control fusion protein were imaged by confocal microscopy, 
scored for the presence of TNT-like structures (C) and the length of these structures was measured 
(D). Protrusions connecting cells that lacked contact with the substratum were termed TNT-like 
protrusions. Mean values are indicated within the columns +/- s.d. The formation of TNT-like 
structures was significantly increased (p = 0.009) in LST1-EGFP transfectants when compared with 
cells expressing the control fusion protein (C). TNT-like structures formed by LST1-transfectants 
were also significantly longer (p = 0.009) than the ones observed between control transfectants (D). 
At least 200 cells were analyzed per group in 5 independent experiments. (E) HeLa cells 
overexpressing LST1-EGFP were stained for actin and tubulin. TNT-like protrusions connecting 
transfectants contained LST1-EGFP and actin (E, left and middle insets) but only trace amounts of 
tubulin (E, right inset, not visible). Note that the membrane protrusion was damaged by the 
mechanical stress of fixation and subsequent immunocytochemistry (E, arrow). (F) HeLa cells 
coexpressing LST1-mCherry (red) and EGFP-tubulin (green) were imaged by live-cell confocal 
microscopy. Transfectants were connected by LST1-induced membrane protrusions that lacked 
contact with the substratum (F, lower panel, yz-projection including the substratum plane, 
corresponding to the upper arrow). Thick membrane protrusions (F, asterisk) contained LST1 and 
tubulin while in thin membrane protrusions only LST1 could be detected (F, arrows). 
 
 
Figure 2. LST1 supports the formation of functional nanotubes. Mean values are indicated 
within the columns +/- s.d. (A) HeLa cells transfected with a construct encoding FLAG-LST1 or a 
control vector (pcDNA 3.1) were stained with CFSE or DiI and cocultivated. The number of CFSE-
positive cells containing DiI-stained vesicles and/or organelles was assessed by fluorescence 
microscopy as a measure of nanotube-mediated intercellular transfer. Transfer of stained organelles 
was significantly increased (p = 0.009) between cells overexpressing LST1 in comparison to control 
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transfectants. At least 500 cells were analyzed per group in 5 independent experiments. HeLa cells 
were transfected and stained as above, additionally cocultures were treated with the inhibitor of 
actin polymerization latrunculin-A. Treated cells displayed comparable vesicle transfer rates that 
were substantially reduced when compared with untreated cells. At least 300 cells were analyzed 
per group in 3 independent experiments. (B) Stable HeLa transfectants expressing shRNA targeting 
LST1 or a control shRNA were analyzed as in (A). Transfer of stained organelles was significantly 
decreased (p = 0.049) in LST1 shRNA transfectants when compared to control transfectants. At 
least 300 cells were analyzed per group in 3 independent experiments. (C) Stable HeLa 
transfectants expressing shRNA targeting LST1 or a control shRNA were stained with the 
membrane dye DiI, imaged via confocal microscopy and scored for the presence of nanotubes. 
LST1 shRNA transfectants displayed significantly decreased (p = 0.009) nanotube formation when 
compared to cells expressing the control shRNA. At least 200 cells were analyzed per group in 5 
independent experiments. (D) HeLa cells were cotransfected with the LST1-EGFP construct and 
constructs for the expression of the mutants RalA-28N, RalA-38R, RalA-48W, Cdc42-17N, Rac1-
17N or a control vector (pcDNA 3), imaged by confocal microscopy and scored for the presence of 
nanotubes. Overexpression of RalA-28N, RalA-38R and RalA-48W led to a significant reduction (p 
= 0.009) in nanotube formation when compared to control transfected cells and completely blocked 
the effect of LST1-EGFP overexpression. The overexpression of Cdc42-17N slightly inhibited 
nanotube formation while Rac1-17N had no effect. At least 200 cells were analyzed per group in 5 
independent experiments. 
 
 
Figure 3. LST1 interacts with RalA, M-Sec and the exocyst complex. The indicated proteins 
were overexpressed in HEK-293T cells, followed by lysis and GFP or RFP-specific 
immunoprecipitation. Precipitates were probed via western blot analysis using the indicated 
antibodies. The positions of detected proteins and relevant molecular weight marker bands are 
indicated. (A) Recombinant Myc-RalA clearly coprecipitated with the LST1-EGFP fusion protein, 
but not with EGFP alone (A, upper panel). To ensure that comparable amounts of Myc-RalA were 
expressed, lysates were probed for the recombinant protein (A, middle panel). (B-D) In similar 
experiments, endogenous RalA was found to coprecipitate with LST1-EGFP (B) and endogenous 
LST1 coprecipitated with a mCherry-RalA fusion protein (C). Additionally, endogenous Sec5, a 
component of the exocyst complex, was found to clearly coprecipitate with LST1-EGFP (D). (E-F) 
To investigate whether LST1 influences the interaction between RalA and Sec5, mCherry-RalA 
was coexpressed either with LST1-EGFP or EGFP. Coexpression of LST1-EGFP visibly enhanced 
coprecipitation of Sec5 with mCherry-RalA (E). Quantitative western blot analysis of 
coprecipitation between Sec5 and mCherry-RalA (F). The Sec5 signal intensity was quantified and 
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normalized for the amount of mCherry-RalA precipitated. Mean values from 5 independent 
experiments are indicated within the columns +/- s.d. Overexpression of LST1-EGFP significantly 
(p = 0.009) increased coprecipitation of Sec5 with mCherry-RalA. (G) M-Sec is a known inductor 
of nanotube formation (Hase et al., 2009). The LST1-mCherry fusion protein, but not mCherry 
alone coprecipitated with M-Sec-EGFP. 
 
 
Figure 4. LST1 recruits RalA to the plasma membrane. (A-D) Maximum intensity projections 
of confocal z-slides (A, B) and single z-slides (C, D), images at the substratum plane were not 
included. Scale bar: 20 µm. LST1-EGFP (green) and mCherry-RalA (red) were coexpressed in 
HeLa cells, both fusion proteins colocalized at the cell membrane and were present in nanotubes (A, 
zoom ups). Both fusion proteins were clearly enriched at the base of nanotubes, when compared to 
other positions of the plasma membrane (B, zoom ups). HeLa cells were cotransfected with 
constructs encoding mCherry-RalA and either EGFP (C) or LST1-EGFP (D). In cells 
overexpressing EGFP, mCherry-RalA was localized at the plasma membrane, but also throughout 
the cytoplasm and in internal membranes (C), while in transfectants overexpressing LST1-EGFP, 
the mCherry-RalA fusion protein localized primarily to the plasma membrane and was scarcely 
found throughout the cytoplasm (D). (E-F) Quantitative analysis of RalA membrane localization. 
The fluorescence intensity of mCherry-RalA at the plasma membrane was measured and compared 
to the total fluorescence intensity in 8 z-slides per cell. Mean values are indicated within the 
columns +/- s.d. At least 30 cells were analyzed per group in 3 independent experiments. In cells 
overexpressing LST1-EGFP, the mCherry-RalA fusion protein displayed a significantly (p = 1.01E-
11) increased localization to the cell membrane, when compared with transfectants expressing 
EGFP only. In cells expressing a shRNA targeting LST1, mCherry-RalA membrane localization 
was significantly decreased (p = 0.0002) when compared to transfectants expressing an unspecific 
shRNA. (G) Fluorescence recovery after photobleaching (FRAP) analysis of mCherry-RalA. Cells 
were cotransfected as described above, mCherry-RalA was bleached at the plasma membrane and 
fluorescence recovery was tracked. The time point t = 0 was defined as immediately following 
bleaching, the fluorescence intensity is displayed as percentage of pre-bleaching fluorescence. A 
representative pair of data sets is displayed. mCherry-RalA membrane fluorescence clearly recovers 
more swiftly in cells coexpressing LST1-EGFP, when compared with transfectants coexpressing 
EGFP alone. (H) Quantitative analysis of mCherry-RalA fluorescence recovery. FRAP was 
performed as described above and the time required for the recovery of 50% pre-bleach 
fluorescence intensity was measured. Mean values are indicated within the columns +/- s.d. 
Fluorescence recovery of mCherry-RalA was significantly accelerated (p = 9.78E-8) in cells 
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coexpressing LST1-EGFP, when compared with transfectants coexpressing EGFP alone. At least 30 
cells were analyzed per group in 3 independent experiments.  
 
 
Figure 5. LST1 recruits filamin to the plasma membrane. (A) Stable HeLa transfectants 
expressing either LST1-EGFP or EGFP were lysed followed by GFP-specific immunoprecipitation. 
Precipitates were separated via PAGE and proteins were visualized using coomassie staining. The 
positions of detected proteins and relevant molecular weight marker bands are indicated. A 
noticeable band above 175 kDa coprecipitated with LST1-EGFP but not with EGFP (bounding 
boxes). Mass spectrometry analysis of the coprecipitated band identified filamin, myoferlin and the 
myosin II heavy chains MYH9/MYH10. (B) To examine whether the interaction between LST1 and 
filamin is mediated by RalA, LST1-EGFP was coexpressed in HEK-293T cells either with a control 
vector (pcDNA 3), Myc-RalA or Myc-RalA-28N, a dominant negative mutant that is constitutively 
GDP-bound and is therefore unable to bind filamin. The LST1-EGFP fusion protein was 
immunoprecipitated and precipitates were separated both on 6% (upper panel) and 15% (lower 
panels) PAGE gels and examined via western blot analysis using the indicated antibodies. 
Additionally, coprecipitated RalA was detected to ensure that its interaction with LST1-EGFP was 
comparable in all samples (lower panel). (C) Quantitative western blot analysis of coprecipitation 
between filamin and LST1-EGFP. The filamin signal intensity was quantified and normalized for 
the amount of LST1-EGFP precipitated. Mean values from 4 independent experiments are indicated 
within the columns +/- s.d. Overexpression of Myc-RalA significantly (p = 0.028) increased 
coprecipitation of filamin with LST1-EGFP, while overexpression of Myc-RalA-28N significantly 
(p = 0.028) reduced the amount of filamin that coprecipitated with LST1-EGFP. (D-E) Maximum 
intensity projections of confocal z-slides, images at the substratum plane were not included. Scale 
bar: 20 µm. LST1-EGFP (green) was expressed in HeLa cells, which were stained for endogenous 
filamin (red), both proteins colocalized at the cell membrane and in nanotubes (d, zoom up). In cells 
overexpressing LST1-EGFP, endogenous filamin was enriched at the plasma membrane (D), while 
in transfectants overexpressing EGFP, enrichment of endogenous filamin at the plasma membrane 
was not detected (E). (F) Quantitative analysis of filamin membrane localization. Cells were 
transfected as described above, the fluorescence intensity of filamin at the plasma membrane was 
measured and compared to the total fluorescence intensity in 8 z-slides per cell. Mean values are 
indicated within the columns +/- s.d. In cells overexpressing LST1-EGFP, endogenous filamin 
displayed a significantly (p = 4.23E-11) increased localization to the cell membrane, when 
compared with transfectants expressing EGFP only. At least 30 cells were analyzed per group in 3 
independent experiments. 
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Figure 6. Proposed model for the LST1-induced formation of tunneling nanotubes. Arrows 
indicate interactions, “R” indicates plasma membrane recruitment by LST1 and “+” denotes 
promotion of interaction by LST1. Transmembrane LST1 acts as a membrane scaffold for the 
assembly of a multiprotein complex that orchestrates the formation of nanotubes. In our proposed 
model two pathways for membrane and cytoskeletal reorganization converge on LST1 at the plasma 
membrane. First, LST1 recruits the small GTPase RalA and its effector filamin to the plasma 
membrane, thereby inducing localized actin-crosslinking. Second, LST1 promotes the interaction 
between RalA and the exocyst complex at the plasma membrane, thereby enabling exocyst-
mediated actin polymerization and membrane complementation. Additionally, the known inducer of 
nanotube formation M-Sec interacts with LST1 and RalA. The identification of myosin and 
myoferlin as further LST1-interacting proteins indicates that these proteins may contribute to the 
formation of open-ended nanotubes by locally deforming the plasma membrane and enabling 
membrane fusion. 
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
A                                   B                                    C
D                                           E                                    F
p < 0.01
LST1-EGFP      Actin          Tubulin
p < 0.01
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
 A                                           B                                                 C
                              D
p < 0.01
+ 500 nM Lat-A
p < 0.05 p < 0.01
p < 0.01
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
A                                            B                                         C
D                                              E                                            F
 G                                  
LS
T1
-EG
FP
 + M
yc-
Ra
lA 
     
 
     
    
     
     
 
     
     
     
EG
FP
 + M
yc-
Ra
lA
     
     
    
30
30
46
30
kDa
Myc-RalA
Myc-RalA
LST1-EGFP
EGFP
IP: GFP ; WB: anti-Myc
IP: GFP ; WB: anti-GFP
Lysate ; WB: anti-Myc
LS
T1
-EG
FP
     
  
     
    
     
     
 
     
     
     
EG
FP
     
     
    
25
46
30
kDa
IP: GFP ; WB: anti-RalA
IP: GFP ; WB: anti-GFP
RalA
LST1-EGFP
EGFP
LS
T1
-EG
FP
     
  
     
    
     
     
 
     
     
     
EG
FP
     
     
    
80
46
30
kDa
IP: GFP ; WB: anti-Sec5
IP: GFP ; WB: anti-GFP
Sec5
LST1-EGFP
EGFP
IP: RFP ; WB: anti-RFP
LST1
mCherry-RalA
mCherry
mC
he
rry
-Ra
lA 
     
 
     
    
     
     
 
     
     
     
mC
he
rry
     
     
    
IP: RFP ; WB: anti-LST1
17
58
46
30
kDa
mC
he
rry
-Ra
lA 
+ L
ST
1-E
GF
P  
     
     
    
     
     
 
     
     
     
 mC
he
rry
-Ra
lA 
+ E
GF
P
     
     
    
80
58
46
kDa
IP: RFP ; WB: anti-Sec5
IP: RFP ; WB: anti-GFP
Sec5
mCherry-RalA
LST1-EGFP
IP: RFP ; WB: anti-RFP
p < 0.01
M-
Se
c-E
GF
P +
 LS
T1
-m
Ch
err
y   
    
     
    
     
     
 
     
     
     
M-
Se
c-E
GF
P +
 m
Ch
err
y
     
     
    
LST1-mCherry
M-Sec-EGFP
46
30
175
80
kDa
IP: GFP ; WB: anti-RFP
IP: GFP ; WB: anti-GFP
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
A                                                                B                                   
                                              LST1-
                                              EGFP 
                                              mCherry-
                                              RalA
C                                            D                                             E
F                                                 G                                                   H               
p < 0.0001
EGFP + mCherry-RalA                           LST1-EGFP + mCherry-RalA
p < 0.0001
LST1-
EGFP
mCherry-
RalA
p < 0.001
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
A                                      B                                                  C
D                                          E                                           F
LS
T1
-EG
FP
     
  
     
    
     
     
 
     
     
     
EG
FP
     
     
    
IP: GFP ; Coomassie staining
175
80
58
46
30
25
kDa
LST1-
EGFP
EGFP
260
46
30
25
kDa
LS
T1
-EG
FP
 + M
yc-
Ra
lA 
     
 
     
    
     
     
 
     
     
     
  LS
T1
-EG
FP
 + M
yc-
Ra
lA-
28N
     
     
     
     
    L
ST
1-E
GF
P +
 Ve
cto
r c
on
tro
l
     
     
    
IP: GFP ; WB: anti-Filamin
IP: GFP ; WB: anti-GFP
IP: GFP ; WB: anti-RalA
Filamin
LST1-EGFP
Myc-RalA
RalA
p < 0.05
LST1-EGFP          Filamin                                  EGFP              Filamin
p < 0.0001
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
L
S
T
1
RalA
Sec5
F
il
a
m
in
Exo
70
Exo84
Actin 
crosslinking
Actin polymerization 
               & membrane complementation
E
x
o
c
y
s
t 
c
o
m
p
le
x
+
M-Sec
Sec6
R
R
Jo
ur
na
l o
f C
el
l S
ci
en
ce
A
cc
ep
te
d 
m
an
us
cr
ip
t
